These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 19661251
1. How are we creating fluoroquinolone-resistant tuberculosis? Bernardo J, Yew WW. Am J Respir Crit Care Med; 2009 Aug 15; 180(4):288-9. PubMed ID: 19661251 [No Abstract] [Full Text] [Related]
2. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis]. Sokolova GB, Kirtaeva OV, Lazareva IaV, Tsybanev AA. Antibiot Khimioter; 2008 Aug 15; 53(5-6):28-31. PubMed ID: 19069179 [No Abstract] [Full Text] [Related]
3. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective]. Lazareva NB, Khaĭmenova TIu, Khaĭmenov AIa. Antibiot Khimioter; 2008 Aug 15; 53(5-6):14-20. PubMed ID: 19069177 [No Abstract] [Full Text] [Related]
4. [Multidrug-resistant tuberculosis in Romania]. Stoicescu IP, Didilescu C, Bercea O. Pneumoftiziologia; 1997 Aug 15; 46(3):161-78. PubMed ID: 9654954 [No Abstract] [Full Text] [Related]
5. [Sparfloxacin in combined therapy for pulmonary tuberculosis]. Sokolova GB, Khaĭmenova TIu, Lazareva IaV, Khaĭmenov AIa. Antibiot Khimioter; 2008 Aug 15; 53(5-6):21-7. PubMed ID: 19069178 [Abstract] [Full Text] [Related]
6. [Maxaquin in the combined treatment of tuberculosis]. Sokolova GB, Mozhokina GN, Kunichan AD, Elistratova NA, Perel'man MI. Probl Tuberk; 2000 Aug 15; (5):35-9. PubMed ID: 11077850 [Abstract] [Full Text] [Related]
7. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones. Chiang CY. Int J Tuberc Lung Dis; 2009 Nov 15; 13(11):1319. PubMed ID: 19861001 [No Abstract] [Full Text] [Related]
8. [Reasons for drug-resistant tuberculosis emergence]. Tu DH. Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 15; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
9. [Difficulties in the treatment of pulmonary tuberculosis in children]. Brînză N, Mihăescu T. Rev Med Chir Soc Med Nat Iasi; 2007 Jun 15; 111(4):852-5. PubMed ID: 18389769 [Abstract] [Full Text] [Related]
10. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens]. Mar'iandyshev AO, Klinberg NM, Shonbina AI, Moroz MI. Probl Tuberk; 1997 Jun 15; (4):19-21. PubMed ID: 9333808 [Abstract] [Full Text] [Related]
11. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations? Yew WW, Koh WJ. Korean J Intern Med; 2016 Jan 15; 31(1):15-29. PubMed ID: 26767853 [Abstract] [Full Text] [Related]
12. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains]. Zhukova MP. Probl Tuberk; 1997 Jan 15; (5):12-5. PubMed ID: 9454239 [Abstract] [Full Text] [Related]
13. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs]. Reichlin S, Frei R, Reusser P. Schweiz Med Wochenschr; 1998 Feb 14; 128(7):264-7. PubMed ID: 9540152 [Abstract] [Full Text] [Related]
14. Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective. Low DE. Clin Infect Dis; 2009 May 15; 48(10):1361-3. PubMed ID: 19348596 [No Abstract] [Full Text] [Related]
15. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan. Chien JY, Lai CC, Tan CK, Yu CJ, Hsueh PR. Clin Infect Dis; 2013 Apr 15; 56(7):1054-5. PubMed ID: 23175554 [No Abstract] [Full Text] [Related]